We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$50.4B
AUM Growth
-$1.85B
(-3.5%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
19.4%
Holding
826
New
39
Increased
356
Reduced
370
Closed
40
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$283M |
| 2 |
NVIDIA
NVDA
|
+$145M |
| 3 |
Equinix
EQIX
|
+$122M |
| 4 |
Elevance Health
ELV
|
+$122M |
| 5 |
Oracle
ORCL
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Grupo Aeroportuario del Sureste
ASR
|
+$741M |
| 2 |
Meta Platforms (Facebook)
META
|
+$172M |
| 3 |
Apple
AAPL
|
+$169M |
| 4 |
CVS Health
CVS
|
+$162M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$158M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.84% |
| 2 | Technology | 14.93% |
| 3 | Consumer Discretionary | 11.64% |
| 4 | Healthcare | 10.56% |
| 5 | Consumer Staples | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
76
Elevance Health
ELV
$92.9B
| $181M | 0.36% |
825,088
+518,258
| +169% | +$122M |
2017 Q3
2 quarters
|
|
77
Simon Property Group
SPG
$65.8B
| $181M | 0.36% |
1,170,754
+381,970
| +48% | +$60.8M |
2017 Q3
2 quarters
|
|
78
Prologis
PLD
$121B
| $179M | 0.36% |
2,842,453
+648,851
| +30% | +$40.3M |
2017 Q3
2 quarters
|
|
79
Merck
MRK
$358B
| $170M | 0.34% |
3,261,663
-1,455,533
| -31% | -$78.6M |
2017 Q3
2 quarters
|
|
80
Devon Energy
DVN
$54.2B
| $165M | 0.33% |
5,180,910
+174,649
| +3% | +$6.41M |
2017 Q3
2 quarters
|
|
81
Amdocs
DOX
$6.34B
| $165M | 0.33% |
2,466,495
-26,469
| -1% | -$1.78M |
2017 Q3
2 quarters
|
|
82
Fortune Brands Innovations
FBIN
$4.77B
| $161M | 0.32% |
3,202,236
-357,956
| -10% | -$20M |
2017 Q3
2 quarters
|
|
83
Texas Instruments
TXN
$255B
| $160M | 0.32% |
1,544,178
-147,250
| -9% | -$15.9M |
2017 Q3
2 quarters
|
|
84
Trip.com Group
TCOM
$25.1B
| $152M | 0.3% |
3,267,478
-441,084
| -12% | -$20.7M |
2017 Q3
2 quarters
|
|
85
Berkshire Hathaway Class B
BRK.B
$1.13T
| $141M | 0.28% |
705,213
-3,251
| -0.5% | -$668K |
2017 Q3
2 quarters
|
|
86
Walmart Inc
WMT
$935B
| $140M | 0.28% |
4,735,380
-210,774
| -4% | -$6.78M |
2017 Q3
2 quarters
|
|
87
Grupo Aeroportuario Centro Norte
OMAB
$4.41B
| $139M | 0.28% |
3,521,947
+409,198
| +13% | +$16.7M |
2017 Q3
2 quarters
|
|
88
Baidu
BIDU
$28.1B
| $139M | 0.27% |
620,933
-46,344
| -7% | -$11.4M |
2017 Q3
2 quarters
|
|
89
Accenture
ACN
$138B
| $136M | 0.27% |
884,866
+39,064
| +5% | +$6.19M |
2017 Q3
2 quarters
|
|
90
Procter & Gamble
PG
$365B
| $136M | 0.27% |
1,709,573
+19,402
| +1% | +$1.62M |
2017 Q3
2 quarters
|
|
91
Welltower
WELL
$169B
| $133M | 0.26% |
2,437,286
+543,502
| +29% | +$30.7M |
2017 Q3
2 quarters
|
|
92
Gilead Sciences
GILD
$195B
| $132M | 0.26% |
1,750,608
-183,129
| -9% | -$14.6M |
2017 Q3
2 quarters
|
|
|
93
CVS Health
CVS
$118B
| $132M | 0.26% |
2,119,660
-2,258,023
| -52% | -$162M |
2017 Q3
2 quarters
|
|
94
HDFC Bank
HDB
$121B
| $130M | 0.26% |
5,258,320
-426,000
| -7% | -$10.7M |
2017 Q3
2 quarters
|
|
95
Alexandria Real Estate Equities
ARE
$7.29B
| $129M | 0.26% |
1,036,778
+156,610
| +18% | +$19.4M |
2017 Q3
2 quarters
|
|
96
Knight Transportation
KNX
$10.6B
| $129M | 0.25% |
2,792,362
-2,363,001
| -46% | -$112M |
2017 Q4
1 quarter
|
|
97
Morgan Stanley
MS
$286B
| $127M | 0.25% |
2,348,738
-717,662
| -23% | -$39.7M |
2017 Q3
2 quarters
|
|
98
JD.com
JD
$37B
| $124M | 0.24% |
3,050,413
-21,754
| -0.7% | -$986K |
2017 Q3
2 quarters
|
|
99
Lumen Technologies, Inc. Common Stock
LUMN
$5.02B
| $123M | 0.24% |
7,511,004
+828,981
| +12% | +$14.4M |
2017 Q3
2 quarters
|
|
100
Eli Lilly
LLY
$1.12T
| $123M | 0.24% |
1,583,053
-668,927
| -30% | -$53.9M |
2017 Q3
2 quarters
|
|
Similar funds
Aberdeen Group's Q1 2018 Portfolio in Review
As of Q1 2018, Aberdeen Group held 826 positions worth $50.4B, down 3.5% from $52.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group's Q1 2018 filing shows 39 new, 356 increased, 370 reduced and 40 closed positions. Its largest new stake was Marvell Technology: 12,380,623 shares worth $260M. The largest sale was Grupo Aeroportuario del Sureste, an estimated $741M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
- Aberdeen Group's largest Q1 2018 buy was Marvell Technology: 12,380,623 shares worth $260M.
- Aberdeen Group added most to NVIDIA in Q1 2018, an estimated $145M increase.
- Aberdeen Group's biggest Q1 2018 reduction was Grupo Aeroportuario del Sureste, cutting an estimated $741M.
- Aberdeen Group fully exited Allergan plc in Q1 2018, selling an estimated $144M.
- Aberdeen Group's ten largest holdings make up 19% of its $50.4B portfolio in Q1 2018.
- Aberdeen Group opened 39 new positions and closed 40 in Q1 2018.
- Aberdeen Group's portfolio value fell 3.5% quarter-over-quarter to $50.4B.
Based on Aberdeen Group's 13F filing for Q1 2018, filed 15 May 2018.